Klebsiella pneumoniae carbapenemase-producing organisms: An ounce of prevention really is worth a pound of cure

Infection Control and Hospital Epidemiology

Volumn 29, Issue 12, 2008, Pages 1107-1109

  Srinivasan, Arjun ^a   Patel, Jean B ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; POLYMYXIN B; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; KLEBSIELLA PNEUMONIAE; NOTE; UNITED STATES;

BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; HUMANS; KLEBSIELLA PNEUMONIAE; RISK FACTORS; UNITED STATES;

EID: 56749155898     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/594129     Document Type: Note

References (9)

1. Yigit H., Queenan AM, Andersen GJ, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45:1151-1161.
2. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20:440-458.
3. Rice LB, Carias LL, Hutton RA, Rudin SD, Endimiani A, Bonomo RA. The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae. Antimicrob Agents Chemother 2008; 52:3427-3429.
4. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29:1099-1106 (in this issue).
5. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-b-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001; 7:88-91.
6. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007; 51:3026-3029.
7. Samra Z, Ofir O, Lishtzinsky Y, Mador-Shapiro L, Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007; 30:525-529.
8. Stürenburg E, Mack D. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003; 47:273-295.
9. Management of Multi-Drug Resistant Organisms in Healthcare Settings, 2006. Healthcare Infection Control Practices Advisory Committee. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed October 17, 2008.